Laborate Pharmaceuticals India Limited

laborate.com

Indian based Global Pharmaceuticals company with one of the fastest growing rate in the Industry! Laborate was started in 1985 with the mission to help this world specially the poor with better healthcare facility. Our team is working hard in over 35 countries around the globe to serve the mission with excellence. Laborate is certified y World Health Organisation (WHO) and Joint accreditation System of Australia and New Zealand. We take pride on our self for providing excellent healthcare service at affordable price!

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

FOUNDATION MEDICINE ANNOUNCES STRATEGIC COLLABORATION WITH ARVINAS

Foundation Medicine | June 06, 2022

news image

Foundation Medicine, Inc., a pioneer in molecular profiling for cancer, announced a collaboration with Arvinas, Inc., to develop FoundationOne®Liquid CDx as a companion diagnostic for use with Arvinas’ bavdegalutamide an investigational novel PROTAC® protein degrader targeting the androgen receptor (AR). Arvinas’ bavdegalutamide is being developed for the potential treatment of men with metastatic castration resistant prostate cancer who have progressed on existing therapies....

Read More

Pharma Tech

CAPACITY AND CITELINE CONNECT PARTNER FOR AI-POWERED CLINICAL TRIAL RECRUITMENT EXPERIENCE

Capacity | August 12, 2021

news image

Capacity, an AI-powered support automation platform, today announces its partnership with Citeline Connect, the all-in-one clinical trial recruitment platform developed by Informa Pharma Intelligence. The companies partnered to launch Moderna's clinical trial recruitment website with an AI-powered chatbot to provide a comprehensive experience for potential study participants. This partnership enables customers like Moderna to create engaging clinical trial recruitment websites...

Read More

Business Insights

FUISZ PHARMA LLC RECEIVES A PATENT FOR A NON-INVASIVE UROLOGICAL DEVICE TO TREAT BENIGN PROSTATE HYPERPLASIA SYMPTOMS (BPH)

FUISZ LLC | April 19, 2022

news image

The first patent for Fuisz Pharma LLC's non-invasive urological device platform to alleviate symptoms of BPH, US 11,213,41, entitled "Device and Method for Reducing Urinary Retention," was issued via Fuisz LLC. Fuisz Pharma LLC is still looking for additional patent protection to go along with the one that was obtained. The Fuisz device is non-invasive, simple to use, and has been shown to help initiate urination, minimize dribbling and nocturia, and decrease urine r...

Read More

PHARMACY MARKET, PHARMA TECH

KINDEVA DRUG DELIVERY, CHIESI GROUP, AND H&T PRESSPART ANNOUNCE STRATEGIC PARTNERSHIP FOR DOSE COUNTER TECHNOLOGY PRODUCTION

Businesswire | July 12, 2023

news image

Kindeva Drug Delivery, a global leader in contract drug delivery development and manufacturing services and technology, and H&T Presspart (a division of the Heitkamp & Thumann Group), a market leader in respiratory drug delivery systems design, development, and manufacturing, are partnering with Chiesi Group, an international research-focused biopharmaceutical and healthcare group, for the installation of a production line for dose counter (DC) and dose indicator (DI) devices. Comb...

Read More
news image

Business Insights

FOUNDATION MEDICINE ANNOUNCES STRATEGIC COLLABORATION WITH ARVINAS

Foundation Medicine | June 06, 2022

Foundation Medicine, Inc., a pioneer in molecular profiling for cancer, announced a collaboration with Arvinas, Inc., to develop FoundationOne®Liquid CDx as a companion diagnostic for use with Arvinas’ bavdegalutamide an investigational novel PROTAC® protein degrader targeting the androgen receptor (AR). Arvinas’ bavdegalutamide is being developed for the potential treatment of men with metastatic castration resistant prostate cancer who have progressed on existing therapies....

Read More
news image

Pharma Tech

CAPACITY AND CITELINE CONNECT PARTNER FOR AI-POWERED CLINICAL TRIAL RECRUITMENT EXPERIENCE

Capacity | August 12, 2021

Capacity, an AI-powered support automation platform, today announces its partnership with Citeline Connect, the all-in-one clinical trial recruitment platform developed by Informa Pharma Intelligence. The companies partnered to launch Moderna's clinical trial recruitment website with an AI-powered chatbot to provide a comprehensive experience for potential study participants. This partnership enables customers like Moderna to create engaging clinical trial recruitment websites...

Read More
news image

Business Insights

FUISZ PHARMA LLC RECEIVES A PATENT FOR A NON-INVASIVE UROLOGICAL DEVICE TO TREAT BENIGN PROSTATE HYPERPLASIA SYMPTOMS (BPH)

FUISZ LLC | April 19, 2022

The first patent for Fuisz Pharma LLC's non-invasive urological device platform to alleviate symptoms of BPH, US 11,213,41, entitled "Device and Method for Reducing Urinary Retention," was issued via Fuisz LLC. Fuisz Pharma LLC is still looking for additional patent protection to go along with the one that was obtained. The Fuisz device is non-invasive, simple to use, and has been shown to help initiate urination, minimize dribbling and nocturia, and decrease urine r...

Read More
news image

PHARMACY MARKET, PHARMA TECH

KINDEVA DRUG DELIVERY, CHIESI GROUP, AND H&T PRESSPART ANNOUNCE STRATEGIC PARTNERSHIP FOR DOSE COUNTER TECHNOLOGY PRODUCTION

Businesswire | July 12, 2023

Kindeva Drug Delivery, a global leader in contract drug delivery development and manufacturing services and technology, and H&T Presspart (a division of the Heitkamp & Thumann Group), a market leader in respiratory drug delivery systems design, development, and manufacturing, are partnering with Chiesi Group, an international research-focused biopharmaceutical and healthcare group, for the installation of a production line for dose counter (DC) and dose indicator (DI) devices. Comb...

Read More